Compounds > glucuronyl-glucosamine-glycan-sulfate

glucuronyl-glucosamine-glycan-sulfate and Hyperlipoproteinemia-Type-IV

glucuronyl-glucosamine-glycan-sulfate has been researched along with Hyperlipoproteinemia-Type-IV* in 5 studies

Trials

2 trial(s) available for glucuronyl-glucosamine-glycan-sulfate and Hyperlipoproteinemia-Type-IV

Article	Year
Effects of short-term treatment with coenzyme A or sulodexide on plasma lipids in patients with hypertriglyceridemia (type IV) or mixed hyperlipemia (type IIb). International journal of clinical pharmacology, therapy, and toxicology, 1986, Volume: 24, Issue:7 Twenty-seven inpatients suffering from type II and IV dyslipidemia, randomly divided into two groups of 14 and 13 subjects, were treated with coenzyme A (2,000 Lipmann U daily) and sulodexide (300 Lipasemic U daily), respectively, in both cases administered intravenously for 20 days. The principial plasma lipid parameters (total and HDL-cholesterol, LDL-cholesterol in subjects with triglyceridemia less than 400 mg/dl, triglycerides, apoproteins and lipoproteins) were recorded before and after treatment. Tests on patients included an assessment, on a semiquantitative scale, of symptoms arising from modifications of blood flow to the various organs. Statistical analysis of data demonstrated that coenzyme A has a significant cholesterol-lowering action (with an increase in HDL-cholesterol) and a more pronounced hypotriglyceridemic effect in both types of dyslipidemia considered, results on both variables proving more satisfactory than with the control drug. Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coenzyme A; Female; Glycosaminoglycans; Humans; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Lipids; Male; Middle Aged; Random Allocation; Time Factors; Triglycerides	1986
Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial. Monographs on atherosclerosis, 1986, Volume: 14 Topics: Aged; Arteriosclerosis; Blood Viscosity; Clinical Trials as Topic; Double-Blind Method; Female; Glycosaminoglycans; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipids; Male; Middle Aged; Risk	1986

Article

Year

Effects of short-term treatment with coenzyme A or sulodexide on plasma lipids in patients with hypertriglyceridemia (type IV) or mixed hyperlipemia (type IIb).

International journal of clinical pharmacology, therapy, and toxicology, 1986, Volume: 24, Issue:7

Twenty-seven inpatients suffering from type II and IV dyslipidemia, randomly divided into two groups of 14 and 13 subjects, were treated with coenzyme A (2,000 Lipmann U daily) and sulodexide (300 Lipasemic U daily), respectively, in both cases administered intravenously for 20 days. The principial plasma lipid parameters (total and HDL-cholesterol, LDL-cholesterol in subjects with triglyceridemia less than 400 mg/dl, triglycerides, apoproteins and lipoproteins) were recorded before and after treatment. Tests on patients included an assessment, on a semiquantitative scale, of symptoms arising from modifications of blood flow to the various organs. Statistical analysis of data demonstrated that coenzyme A has a significant cholesterol-lowering action (with an increase in HDL-cholesterol) and a more pronounced hypotriglyceridemic effect in both types of dyslipidemia considered, results on both variables proving more satisfactory than with the control drug.

Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coenzyme A; Female; Glycosaminoglycans; Humans; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Lipids; Male; Middle Aged; Random Allocation; Time Factors; Triglycerides

1986

Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.

Monographs on atherosclerosis, 1986, Volume: 14

Topics: Aged; Arteriosclerosis; Blood Viscosity; Clinical Trials as Topic; Double-Blind Method; Female; Glycosaminoglycans; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipids; Male; Middle Aged; Risk

1986

Other Studies

3 other study(ies) available for glucuronyl-glucosamine-glycan-sulfate and Hyperlipoproteinemia-Type-IV

Article	Year
[Evaluation of a sulfomucopolysaccharide (3GS) in the treatment of hyperlipoproteinemias]. La Clinica terapeutica, 1982, Jun-30, Volume: 101, Issue:6 Topics: Aged; Cerebrovascular Disorders; Female; Glycosaminoglycans; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Placebos; Vascular Diseases	1982
[Long-term effects of a glycosaminoglycan on plasma lipids]. La Clinica terapeutica, 1981, Jul-15, Volume: 98, Issue:1 Topics: Adult; Aged; Cholesterol; Female; Glycosaminoglycans; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipids; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides	1981
[Behavior of serum lipids, blood coagulation factors, platelet aggregation, complement and serum immunoglobulins in a group of arteriosclerotic, hyperlipemic subjects treated with 3GS]. La Clinica terapeutica, 1981, Feb-15, Volume: 96, Issue:3 Topics: Adult; Aged; Arteriosclerosis; Blood Coagulation Factors; Complement System Proteins; Female; Glycosaminoglycans; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Immunoglobulins; Lipids; Male; Middle Aged; Platelet Aggregation	1981